These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35851267)

  • 1. Comparison of epidermal growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2) immunohistochemical expression and outcomes in canine nasal carcinomas treated with radiation therapy.
    Fu DR; Kadosawa T
    J Vet Med Sci; 2022 Sep; 84(9):1237-1243. PubMed ID: 35851267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy.
    Belshaw Z; Constantio-Casas F; Brearley MJ; Dunning MD; Holmes MA; Dobson JM
    Vet Comp Oncol; 2011 Jun; 9(2):141-8. PubMed ID: 21569199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclooxygenase-2 in canine nasal carcinomas.
    Impellizeri JA; Esplin DG
    Vet J; 2008 Jun; 176(3):408-10. PubMed ID: 17517527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma.
    Cancedda S; Sabattini S; Bettini G; Leone VF; Laganga P; Rossi F; Terragni R; Gnudi G; Vignoli M
    Vet Radiol Ultrasound; 2015; 56(3):335-43. PubMed ID: 25703137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours.
    Shiomitsu K; Johnson CL; Malarkey DE; Pruitt AF; Thrall DE
    Vet Comp Oncol; 2009 Jun; 7(2):106-14. PubMed ID: 19453364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and survival following radiation therapy for canine nasal tumors: A single-institution retrospective study of 166 cases.
    Mizuno R; Mori T
    Open Vet J; 2024 Jul; 14(7):1538-1552. PubMed ID: 39175976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic utility of apoptosis index, Ki-67 and survivin expression in dogs with nasal carcinoma treated with orthovoltage radiation therapy.
    Fu DR; Kato D; Watabe A; Endo Y; Kadosawa T
    J Vet Med Sci; 2014 Nov; 76(11):1505-12. PubMed ID: 25452259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cyclooxygenase-2 in canine epithelial nasal tumors.
    Kleiter M; Malarkey DE; Ruslander DE; Thrall DE
    Vet Radiol Ultrasound; 2004; 45(3):255-60. PubMed ID: 15200266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours.
    Guimarães MJ; Carvalho MI; Pires I; Prada J; Gil AG; Lopes C; Queiroga FL
    J Comp Pathol; 2014 Jan; 150(1):27-34. PubMed ID: 24060154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas.
    Borzacchiello G; Paciello O; Papparella S
    J Comp Pathol; 2004 Jul; 131(1):70-6. PubMed ID: 15144801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma.
    Pan J; Tang T; Xu L; Lu JJ; Lin S; Qiu S; Chen G; K Tham IW
    Head Neck; 2013 Sep; 35(9):1238-47. PubMed ID: 22972415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of cyclooxygenase-2 in canine ovarian carcinomas.
    Borzacchiello G; Russo V; Russo M
    J Vet Med A Physiol Pathol Clin Med; 2007 Jun; 54(5):247-9. PubMed ID: 17523957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of midline shift of the olfactory or frontal lobes of the brain in canine nasal carcinomas treated by palliative radiotherapy: a pilot study.
    Wada Y; Noguchi S; Sasaki H; Taketomi A; Hamakawa M; Shimamura S; Shimada T
    J Vet Med Sci; 2018 Nov; 80(11):1724-1727. PubMed ID: 30305466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.
    Pastor N; Ezquerra LJ; Santella M; Caballé NC; Tarazona R; Durán ME
    Vet Comp Oncol; 2020 Dec; 18(4):753-762. PubMed ID: 32336005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor receptor-2, epidermal growth factor receptor, cyclooxygenase-2, survivin, E-cadherin and Ki-67 in canine nasal carcinomas and sarcomas - a pilot study.
    Pauly LAM; Junginger J; Oechtering GU; Hewicker-Trautwein M; Rösch S
    Front Vet Sci; 2024; 11():1388493. PubMed ID: 39268521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
    Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tumor volume reduction of nasal carcinomas versus sarcomas in dogs treated with definitive fractionated megavoltage radiation: 15 cases (2010-2016).
    Morgan MJ; Lurie DM; Villamil AJ
    BMC Res Notes; 2018 Jan; 11(1):70. PubMed ID: 29361976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor tyrosine kinase expression and phosphorylation in canine nasal carcinoma.
    Hocker SE; Higginbotham ML; Schermerhorn T; Henningson J
    Res Vet Sci; 2017 Dec; 115():484-489. PubMed ID: 28783596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
    Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
    Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.